Join us for an alliance member-only meeting that will take place on Tuesday, April 7, at 11 a.m. ET. We are thrilled to be joined by Nick Bath, Partner at Manatt, Phelps & Phillips. We will dig into the president's budget and other critical research and public health advocacy issues (e.g., updates on AHRQ, FDA, and […]
In 2023, nearly 25% of adults in the US had chronic pain, with nearly 10% of those cases frequently limiting life or work activities. Gaps in research and data hinder progress against this pervasive health issue. Join us on April 9th at 12:00 p.m. ET, for a discussion with Siobhan Murray from the office of Senator Tim Kaine (D-VA). Senator Kaine […]
Join us for a special Zoom meeting on Thursday, April 23 from 11:30 a.m. to 12:15 p.m. ET featuring Meghan Mott and Stephen Steigleder, Professional Staff Members for the Minority on the Senate and House Labor-HHS Subcommittees, respectively. Meghan and Stephen will provide an update on the FY27 appropriations process, with a particular focus on the NIH. This off-the-record discussion is not open to […]
On April 30, 2026, we hosted a discussion with Amy Comstock Rick,, Associate Director for Rare Disease Strategy at the Center for Drug Evaluation and Research (CDER) and Director of Strategic Coalitions for the Rare Disease Innovation Hub at the FDA. During this virtual event, Amy discussed the FDA's work to advance treatments for people […]
On Thursday, May 14, at noon ET we hosted an alliance member-only discussion featuring Cheryl Jaeger of Crossroads Strategies. We asked Cheryl to provide an update on the latest in the FY27 appropriations process, the dissolution of the National Science Board, and other key R&D-relevant developments.
On May 21, 2026, we hosted an engaging Alliance Discussion with Dr. Alicia Jackson, Director of ARPA-H. Dr. Jackson shared her vision and priorities for this important federal agency and provided a brief overview of the current project landscape. This conversation was moderated by Research!America President and CEO Russ Paulsen. Watch the recording.
In partnership with the National Health Council, Research!America invites you to participate in a National Institute of Nursing Research (NINR) listening session on Wednesday, May 27, from 9:30 to 11:00 a.m. ET. The session (in-person only) will be held at the Barbara Jordan Conference Center, located at 1330 G St NW in Washington, D.C. This interactive session is part of […]
We hosted a special alliance member-only discussion on June 3, from 12:00 to 1:00 p.m. ET featuring Carrie Wolinetz, Ph.D., Senior Principal at Lewis-Burke Associates. Carrie discussed the newly proposed OMB rule, “Regulation for Federal Financial Assistance,” and what it could mean for federally funded research grants and the broader research ecosystem. This interactive discussion provided […]
We hosted an alliance member-only discussion on Thursday, June 4, at noon ET with Salim Alameddin, Executive Vice President at Crossroads Strategies, and Joel Burke, AI Policy Adviser for Senator Mike Rounds (R-SD). During this conversation, they provided an update on the Administration’s priorities around artificial intelligence and the latest AI-related activity on Capitol Hill.
We hosted an alliance member-only discussion on Wednesday, June 10, from 12:00 – 1:00 p.m. ET Ellie Dehoney, Senior Vice President of Policy & Advocacy, provided a Washington update with a focus on the Labor-HHS appropriations bill, including key funding levels and policy provisions following subcommittee and full committee markups. As always, we touched on […]
Crafting Public Comments for OMB’s Proposed Rule: On June 17, 2026, we hosted a webinar discussing the basics of submitting comments in response to OMB's proposed rule on Regulation For Federal Financial Assistance. We were pleased to host Mark Barnes and Dr. Leslie Thornton from Ropes & Gray, and Dr. Yvette Seger, for this interactive discussion. View the Slides. Watch the […]
Please join Research!America for a congressional briefing will explore the life-changing potential of Genetically Targeted Technology (GTT) through the eyes of the patients it serves.
